Published in Cell Immunol on April 15, 1991
Continuous engagement of a self-specific activation receptor induces NK cell tolerance. J Exp Med (2008) 1.86
Heterogeneity among Ly-49C natural killer (NK) cells: characterization of highly related receptors with differing functions and expression patterns. J Exp Med (1996) 1.14
Receptor/ligand avidity determines the capacity of Ly49 inhibitory receptors to interfere with T-cell receptor-mediated activation. Immunology (2003) 0.78
Classification of European mtDNAs from an analysis of three European populations. Genetics (1996) 6.28
Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat Med (1998) 4.17
Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med (1998) 3.09
Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med (1999) 3.08
Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med (1995) 2.75
p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J Exp Med (1997) 2.70
bcl-2 expression in pleural and extrapleural solitary fibrous tumours. J Pathol (1997) 2.66
Identification of a new group of bovine viral diarrhea virus strains associated with severe outbreaks and high mortalities. Virology (1994) 2.34
DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinase. J Biol Chem (1998) 2.10
Demonstration of safety of probiotics -- a review. Int J Food Microbiol (1998) 2.02
Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J Exp Med (1994) 1.98
Thrombosis in the portal venous system after elective laparoscopic splenectomy. Surg Endosc (2004) 1.92
Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract. J Appl Microbiol (1998) 1.90
Drug resistance plasmids in Lactobacillus acidophilus and Lactobacillus reuteri. Appl Environ Microbiol (1982) 1.83
Conjugal Transfer of Broad-Host-Range Plasmid pAMbeta1 into Enteric Species of Lactic Acid Bacteria. Appl Environ Microbiol (1983) 1.68
Evaluation of the ability of antioxidants to counteract lipid oxidation: existing methods, new trends and challenges. Prog Lipid Res (2007) 1.62
Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis. J Infect Dis (1999) 1.58
Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies. Diagn Pathol (2011) 1.57
Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains. Neurochem Res (2000) 1.46
The distribution of HLA class II haplotypes reveals that the Sardinian population is genetically differentiated from the other Caucasian populations. Tissue Antigens (2000) 1.44
Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur J Immunol (1999) 1.42
Safety of recreational scuba diving in type 1 diabetic patients: the Deep Monitoring programme. Diabetes Metab (2009) 1.42
Multicentric evaluation of the MDR phenotype in leukemia. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hôpitaux de Paris. Leukemia (1997) 1.41
Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer. Clin Cancer Res (1995) 1.39
Functions of S-layers. FEMS Microbiol Rev (1997) 1.38
Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells. Eur J Immunol (1994) 1.32
Peopling of three Mediterranean islands (Corsica, Sardinia, and Sicily) inferred by Y-chromosome biallelic variability. Am J Phys Anthropol (2003) 1.30
A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur J Immunol (1996) 1.29
Archival, demographic and genetic studies define a Sardinian sub-isolate as a suitable model for mapping complex traits. Hum Genet (2001) 1.28
Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia. Genes Immun (2008) 1.27
Experimental manipulation of intolerance of uncertainty: a study of a theoretical model of worry. Behav Res Ther (2000) 1.25
High diversity of oilseed rape pollen clouds over an agro-ecosystem indicates long-distance dispersal. Mol Ecol (2005) 1.24
Antibiotic susceptibility of potentially probiotic Lactobacillus species. J Food Prot (1998) 1.23
Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans. Infect Immun (2000) 1.20
The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase. Eur J Immunol (1994) 1.18
Russell body gastritis associated with Helicobacter pylori infection in an HIV-positive patient: case report and review of the literature. Z Gastroenterol (2009) 1.15
The inter-regional distribution of HLA class II haplotypes indicates the suitability of the Sardinian population for case-control association studies in complex diseases. Hum Mol Genet (2000) 1.15
Bcl-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-up. Hum Pathol (1996) 1.15
In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors. J Exp Med (1991) 1.15
Prognostic value of p21(WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up. Clin Cancer Res (1996) 1.14
Insulin-degrading enzyme: structure-function relationship and its possible roles in health and disease. Curr Pharm Des (2009) 1.12
On the fate of ingested Bacillus spores. Res Microbiol (2000) 1.11
Selective detection, enumeration and identification of potentially probiotic Lactobacillus and Bifidobacterium species in mixed bacterial populations. Int J Food Microbiol (1997) 1.10
A radioimmunoassay for the measurement of blood group Ii activities: its application to glycoconjugates, oligosaccharides and intact cells. Mol Immunol (1979) 1.07
Kappa chain (V kappa III) subgroup-related activity in an idiotypic anti-cold agglutinin serum. Scand J Immunol (1976) 1.07
Role of a STAT binding site in the regulation of the human perforin promoter. J Immunol (1999) 1.07
CD45-mediated regulation of LFA1 function in human natural killer cells. Anti-CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA1 molecules. Eur J Immunol (1993) 1.06
Characterization of an associated 16-kDa tyrosine phosphoprotein required for Ly-49D signal transduction. J Immunol (1998) 1.06
[Angioneurotic edema caused by exertion]. Pediatrie (1966) 1.06
Iron requirement of Lactobacillus spp. in completely chemically defined growth media. J Appl Microbiol (2000) 1.06
Evidence of genomic variations between infectious pancreatic necrosis virus strains determined by restriction fragment profiles. J Gen Virol (1992) 1.05
Age-specific mating strategies and reproductive senescence. Mol Ecol (2005) 1.05
Bovine viral diarrhea virus proteins: heterogeneity of cytopathogenic and non-cytopathogenic strains and evidence of a 53K glycoprotein neutralization epitope. Vet Microbiol (1988) 1.05
p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival. Br J Cancer (1996) 1.04
A 70-kilodalton recombinant heat shock protein of Candida albicans is highly immunogenic and enhances systemic murine candidiasis. Infect Immun (1998) 1.04
The S-layer gene of Lactobacillus helveticus CNRZ 892: cloning, sequence and heterologous expression. Microbiology (1998) 1.01
Defective ubiquitination of cerebral proteins in Alzheimer's disease. J Neurosci Res (2000) 1.01
S-layer gene as a molecular marker for identification of Lactobacillus helveticus. FEMS Microbiol Lett (2000) 1.01
Multiple paternity in clutches of common lizard Lacerta vivipara: data from microsatellite markers. Mol Ecol (2004) 1.00
Rapid amplified ribosomal DNA restriction analysis (ARDRA) identification of Lactobacillus spp. isolated from fecal and vaginal samples. Syst Appl Microbiol (2000) 1.00
Gradient diffusion antibiotic susceptibility testing of potentially probiotic lactobacilli. J Food Prot (2001) 1.00
Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium. J Clin Oncol (1989) 0.98
Lactobacillus crispatus and its nonaggregating mutant in human colonization trials. J Dairy Sci (2001) 0.98
A common idiotype on human macroglobulins with anti-I and anti-i specificity. Clin Exp Immunol (1975) 0.98
Experimental pathogenicity and acid proteinase secretion of vaginal isolates of Candida parapsilosis. J Med Vet Mycol (1990) 0.97
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics. Br J Cancer (2001) 0.97
The NK2.1 receptor is encoded by Ly-49C and its expression is regulated by MHC class I alleles. Int Immunol (1997) 0.97
Polymerase chain reaction using arbitrary primer for the design and construction of a DNA probe specific for Porphyromonas gingivalis. Res Microbiol (1994) 0.96
Heterogeneity of natural killer cell subsets in NK-1.1+ and NK-1.1- inbred mouse strains and their progeny. Cell Immunol (1992) 0.95
Detection of bovine mitochondrial DNA in ruminant feeds: a molecular approach to test for the presence of bovine-derived materials. J Food Prot (1998) 0.95
A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer. Ann Oncol (2007) 0.95
Lactobacillus protoplast transformation. Plasmid (1987) 0.94
[Bronchomotor reactions of the normal person after blocking of the beta-adrenergic receptors]. Acta Allergol (1968) 0.93
Cyanide Protection against X-Irradiation. Science (1950) 0.93
Evidence of a major neutralizable conformational epitope region on VP2 of infectious pancreatic necrosis virus. J Gen Virol (1995) 0.93
[Antigenic characterization of influenza A virus isolated from birds captured in Ontario, Quebec, and the maritime provinces during the 1977 season]. Rev Can Biol (1980) 0.93
Antibiotic susceptibility of potentially probiotic Bifidobacterium isolates from the human gastrointestinal tract. Lett Appl Microbiol (1998) 0.93
Expression of human NKRP1A by CD34+ immature thymocytes: NKRP1A-mediated regulation of proliferation and cytolytic activity. Eur J Immunol (1996) 0.92
[Isolation of influenza viruses in different species of bird in Canada in 1978]. Rev Can Biol (1981) 0.92
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party. J Clin Oncol (1996) 0.91
Post mortem investigations on cetaceans found stranded on the coasts of Italy between 1990 and 1993. Vet Rec (1995) 0.91
Two distinct protein isoforms are encoded by ntk, a csk-related tyrosine protein kinase gene. Oncogene (1994) 0.91
Novel surface molecules involved in human NK cell activation and triggering of the lytic machinery. Int J Cancer Suppl (1992) 0.91
Comparison of amino acid sequences deduced from a cDNA fragment obtained from infectious pancreatic necrosis virus (IPNV) strains of different serotypes. Virology (1993) 0.91
Erythromycin- and tetracycline-resistant lactobacilli in Italian fermented dry sausages. J Appl Microbiol (2009) 0.90
Animal transmissible spongiform encephalopathies and genetics. Vet Res Commun (2003) 0.90
PrP genotype in Sarda breed sheep and its relevance to scrapie. Brief report. Arch Virol (2001) 0.90
Probiotics: from research to consumer. Dig Liver Dis (2006) 0.90
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations. Eur Respir J (2011) 0.90
A short protocol for micro-purification of nuclear proteins from whole animal tissue. Biotechniques (1991) 0.90
Differential tyrosine phosphorylation of inhibitory versus activating Ly-49 receptor proteins and their recruitment of SHP-1 phosphatase. J Immunol (1997) 0.89
Comparison of methods for concentration and purification of bovine viral diarrhea virus. J Virol Methods (1987) 0.89
Isolation and molecular characterization of beta-lactamase-producing Haemophilus parainfluenzae from the genital tract. Antimicrob Agents Chemother (1987) 0.89
Human brucellosis: immunoblotting analysis of three Brucella abortus antigenic fractions allows the detection of components of diagnostic importance. Medicina (B Aires) (1991) 0.89
Initiation of cytotoxic T-cell response and protection of Balb/c mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccine. Vaccine (1992) 0.88
A phase III randomised study comparing concomitant radiochemotherapy as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer. Lung Cancer (2008) 0.88
Single-stranded DNA plasmid, vector construction and cloning of Bacillus stearothermophilus alpha-amylase in Lactobacillus. Res Microbiol (1992) 0.88
p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans. Eur J Immunol (1995) 0.87